SCOPUS 정보 검색 플랫폼

Drug Metabolism and Disposition

Volumn 29, Issue 5, 2001, Pages 681-685

Biodistribution of 4-[14C]cholesterol-ambisome following a single intravenous administration to rats

(3) Townsend, Robert W a Zutshi, Anup b Bekersky, Ihor a

a ASTELLAS PHARMA GLOBAL DEVELOPMENT (United States)

b BATTELLE MEMORIAL INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG URINE LEVEL; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; STEADY STATE;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; AREA UNDER CURVE; CARBON RADIOISOTOPES; CHOLESTEROL; DRUG CARRIERS; FEMALE; MALE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0035033898 PISSN: 00909556 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (26)

References (20)

1
- 0034469250
- Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): A 91-day study in rats
- (2000) Pharm Res , vol.17 , pp. 1492-1502
- Bekersky, I.¹ Boswell, G.² Hiles, R.³ Fielding, R.M.⁴ Buell, D.⁵ Walsh, T.⁶

2
- 0000219066
- New approaches to systemic antifungal therapy: Case studies of AmBisome and FK463
- (1999) Recent Dev Antimicrob Agents Chemother , vol.3 , pp. 407-413
- Bekersky, I.¹ Buell, D.² Tomishima, M.³ Maki, K.⁴ Lawrence, I.⁵ Fielding, R.M.⁶

3
- 0005081960
- 14C]cholesterol lipid labeled amphotericin B (AmBisome) in healthy subjects
- Abstract 857
- (2000) Proceeding: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 27
- Bekersky, I.¹ Dressler, D.² Fielding, R.M.³ Buell, D.N.⁴ Walsh, T.J.⁵

4
- 0033151650
- Lipid-based amphotericin B formulations: From animals to man
- (1999) Pharm Sci Technol Today , vol.2 , pp. 230-236
- Bekersky, I.¹ Fielding, R.M.² Buell, D.³ Lawrence, I.⁴

5
- 0005053067
- Pharmacokinetics, excretion and mass balance of liposomal amphotericin B (AmBisome) in healthy subjects a phase IV comparison with conventional amphotericin B (Fungizone)
- Abstract 855
- (2000) Proceeding: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 26
- Bekersky, I.¹ Fielding, R.M.² Dressler, D.³ Buell, D.N.⁴ Walsh, T.J.⁵

6
- 0003855039
- Technomic, Lancaster, PA
- (1993) Liposome Drug Delivery Systems
- Betageri, G.V.¹ Jenkins, S.A.² Parsons, D.L.³

7
- 0031893392
- Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of Amphotericin B in rats
- (1998) Antimicrob Agents Chemother , vol.42 , pp. 263-268
- Boswell, G.W.¹ Bekersky, I.² Buell, D.³ Hiles, R.⁴ Walsh, T.J.⁵

8
- 0031904301
- AmBisome (liposomal amphotericin B): A comparative review
- (1998) J Clin Pharmacol , vol.38 , pp. 583-592
- Boswell, G.W.¹ Buell, D.² Bekersky, I.³

9
- 0030806348
- Physiological parameter values for physiological based pharmacokinetic models
- (1997) Toxicol Ind Health , vol.13 , pp. 407-484
- Brown, R.P.¹ Delp, M.D.² Lindstedt, S.L.³ Rhomberg, L.R.⁴ Beliles, R.P.⁵

10
- 0027515338
- Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosls
- (1993) J Antimicrob Chemother , vol.32 , pp. 2391-2398
- Clemons, K.V.¹ Stevens, D.A.²

11
- 0026595038
- Relationship of pharmacokinetics and tissue distribution to reduced toxicity of colloidal amphotericin B in dogs
- (1992) Antimicrob Agents Chemother , vol.36 , pp. 299-307
- Fielding, R.M.¹ Singer, A.W.² Wang, L.H.³ Babbar, S.⁴ Guo, L.S.S.⁵

12
- 0005052127
- (1999) Internal Report no. L1999000019

13
- 0021958862
- Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
- (1985) J Infect Dis , vol.151 , pp. 704-710
- Lopez-Berestein, G.¹ Fainstein, V.² Hopfer, R.³ Mehta, K.⁴ Sullivan, M.P.⁵ Keating, M.⁶ Rosenblum, M.G.⁷ Mehta, R.⁸ Luna, M.⁹ Hersh, E.M.¹⁰

14
- 0003633755
- Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council, National Academy Press
- (1996) Guide for Care and Use of Laboratory Animals

15
- 0026043820
- Pharmacology and toxicology of a liposome formulation of amphotericin B (AmBisome) in rodents
- (1991) J Antimicrob Chemother , vol.28 , Issue.SUPPL. B , pp. 465-472
- Proffitt, R.T.¹ Satorius, A.² Chiang, S.-M.³ Sullivan, L.⁴ Alder-Moore, J.P.⁵

16
- 0030922832
- Amphotericin B lipid complex
- (1997) Ann Pharmacother , vol.31 , pp. 1174-1186
- Rapp, R.P.¹ Gubbins, P.O.² Evans, M.E.³

17
- 0023928370
- Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections
- (1988) Eur J Cancer Clin Oncol , vol.24 , pp. 527-538
- Sculier, J.P.¹ Coune, A.² Meunier, F.³ Brassinne, C.⁴ Laduron, C.⁵ Hollaert, C.⁶ Collette, N.⁷ Heymans, C.⁸ Klastersky, J.⁹

18
- 0033545538
- Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
- (1999) New Engl J Med , vol.340 , pp. 764-771
- Walsh, T.J.¹ Finberg, R.W.² Arndt, C.³ Hiemenz, J.⁴ Schwartz, C.⁵ Bodensteiner, D.⁶ Pappas, P.⁷ Seibal, N.⁸ Greenberg, R.N.⁹ Dummer, S.¹⁰

19
- 0031716174
- Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients
- (1998) Antimicrob Agents Chemother , vol.42 , pp. 2391-2398
- Walsh, T.J.¹ Yeldandi, V.² McEvoy, M.³ Gonzalez, C.⁴ Chanock, S.⁵ Freifeld, A.⁶ Seibel, N.I.⁷ Whitcomb, P.O.⁸ Jarosinski, P.⁹ Boswell, G.¹⁰

20
- 0031729348
- Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: Single dose studies
- (1998) Antimicrob Agents Chemother , vol.42 , pp. 3146-3152
- Wasan, K.M.¹ Kennedy, A.L.² Cassidy, S.M.³ Ramaswamy, M.⁴ Holtorf, L.⁵ Chou, J.W.⁶ Pritchard, P.H.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.